NCT06725966

Brief Summary

Background: Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo, often effectively treated with standard canalith repositioning maneuvers (CRMs). However, approximately 12.5% of cases remain refractory, leading to persistent symptoms and increased healthcare burden. Variations in the anatomical orientation of the semicircular canals (SCCs) may explain the resistance to conventional maneuvers. This study explores a personalized medicine approach, utilizing computational fluid dynamics (CFD) based on MRI reconstructions to tailor CRMs with the help of mechanical rotation chair according to individual inner ear anatomy. Methods: The investigators conducted a randomized, multicenter, open-label study targeting patients with refractory posterior canal BPPV. Participants were allocated to either a control group (receiving repeated standard CRMs and Brandt-Daroff exercises) or an intervention group (receiving personalized CRMs based on CFD simulations derived from MRI scans). The intervention group's maneuvers were executed using a mechanical rotational chair designed for precise angulation. Primary outcomes included resolution of nystagmus and vertigo symptoms, while secondary outcomes measured the reduction in healthcare visits and improved quality of life (Dizziness Handicap Inventory score).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jul 2024Dec 2026

Study Start

First participant enrolled

July 1, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 10, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

December 10, 2024

Status Verified

December 1, 2024

Enrollment Period

2 years

First QC Date

December 2, 2024

Last Update Submit

December 8, 2024

Conditions

Keywords

BPPVBenign paroxysmal positional vertigoComputational fluid dynamicsMRICanalith repositioning maneuversMechanical rotation chair

Outcome Measures

Primary Outcomes (1)

  • Rate of curation

    Percentage of participants in whom, after the maneuvers, no nystagmus is observed in the Dix and Hallpike test

    6 months

Secondary Outcomes (3)

  • Rate of resolution of symptomatology

    6 months

  • DHI score

    6 months

  • Number of sessions

    6 months

Study Arms (2)

Conventional Epley maneuver

ACTIVE COMPARATOR

Participants will be advised to perform Brandt-Daroff exercises at home twice daily for 8 weeks. An MRI of the inner ear and posterior cranial fossa will also be requested. If the exercises are ineffective, repositioning maneuvers using a mechanized chair will be repeated biweekly until symptom resolution.

Procedure: Conventional Epley maneuver

Personalized Epley maneuver

EXPERIMENTAL

Participants will perform Brandt-Daroff exercises at home twice daily for 8 weeks. An MRI will be conducted, and based on the images, a personalized mathematical model will be created to modify the angles of the repositioning maneuver. If the exercises are ineffective, the personalized maneuver will be performed using a mechanized chair.

Procedure: Personalized Epley maneuver

Interventions

Epley maneuver using a mechanized chair

Conventional Epley maneuver

Personalized Epley maneuver, using a mechanized chair

Personalized Epley maneuver

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A. Diagnosed with BPPVp according to the Barany Society criteria:
  • Recurrent episodes of vertigo or positional instability, triggered by lying down or turning the head in the supine position.
  • Episodes lasting less than 1 minute.
  • Positional nystagmus observed after a latency period during the Dix-Hallpike test (DHT), with an upward vertical component and a torsional component (clockwise on the left side and counterclockwise on the right).
  • Symptoms not explained by any other cause.
  • AND
  • B. Refractory to otolith repositioning maneuvers (Epley and/or Semont maneuvers), with persistence of symptoms after three attempts.

You may not qualify if:

  • Cognitive impairment that prevents understanding of their condition and the required procedures.
  • Pathological conditions that hinder the execution of the maneuvers.
  • BPPV involving canals other than the posterior canal or bilateral posterior canal involvement.
  • Low educational level, which may impede understanding of the procedures and informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínico Universitario

Santiago de Compostela, A Coruña, 15706, Spain

RECRUITING

Related Publications (1)

  • Rossi-Izquierdo M, Santos-Perez S, Aran-Tapia I, Blanco-Ulla M, Aran-Gonzalez I, Vaamonde-Sanchez-Andrade I, Franco-Gutierrez V, Perez-Munuzuri V, Munuzuri AP, Soto-Varela A. Personalized medicine to treat refractory benign paroxysmal positional vertigo, through computational fluid dynamics analysis from magnetic resonance image reconstructions. Front Neurol. 2025 Mar 11;16:1561356. doi: 10.3389/fneur.2025.1561356. eCollection 2025.

MeSH Terms

Conditions

Benign Paroxysmal Positional Vertigo

Condition Hierarchy (Ancestors)

VertigoVestibular DiseasesLabyrinth DiseasesEar DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Andrés Soto-Varela, Prof, PhD

    Complexo Hospitalario Universitario de Santiago

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andrés Soto-Varela, Prof, PhD

CONTACT

Ismael Arán-Tapia, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Experimental, multicenter, open-label, randomized study (using balanced block randomization) with two parallel arms
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chairman

Study Record Dates

First Submitted

December 2, 2024

First Posted

December 10, 2024

Study Start

July 1, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

December 10, 2024

Record last verified: 2024-12

Locations